Recent Finacing
Recent Raise
Cardea Bio develops and manufactures graphene-based electronic biosensor hardware, software, and chipsets, including CRISPR-gated transistors, for point-of-need, amplification-free molecular and multi-omics detection in healthcare, agriculture, and environmental monitoring.